91 related articles for article (PubMed ID: 7607504)
1. Genomic sequencing indicates a correlation between DNA hypomethylation in the 5' region of the pS2 gene and its expression in human breast cancer cell lines.
Martin V; Ribieras S; Song-Wang X; Rio MC; Dante R
Gene; 1995 May; 157(1-2):261-4. PubMed ID: 7607504
[TBL] [Abstract][Full Text] [Related]
2. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers.
Martin V; Ribieras S; Song-Wang XG; Lasne Y; Frappart L; Rio MC; Dante R
J Cell Biochem; 1997 Apr; 65(1):95-106. PubMed ID: 9138084
[TBL] [Abstract][Full Text] [Related]
3. Structure of the human oestrogen-responsive gene pS2.
Jeltsch JM; Roberts M; Schatz C; Garnier JM; Brown AM; Chambon P
Nucleic Acids Res; 1987 Feb; 15(4):1401-14. PubMed ID: 3822834
[TBL] [Abstract][Full Text] [Related]
4. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.
Giamarchi C; Solanas M; Chailleux C; Augereau P; Vignon F; Rochefort H; Richard-Foy H
Oncogene; 1999 Jan; 18(2):533-41. PubMed ID: 9927210
[TBL] [Abstract][Full Text] [Related]
5. The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein.
Martin V; Ribieras S; Rio MC; Dante R
Biol Chem; 1998; 379(4-5):409-16. PubMed ID: 9628331
[TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
7. Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma.
Takahashi H; Kida N; Fujii R; Tanaka K; Ohta M; Mori K; Hayashi K
FEBS Lett; 1990 Feb; 261(2):283-6. PubMed ID: 2311759
[TBL] [Abstract][Full Text] [Related]
8. Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3.
Archey WB; Sweet MP; Alig GC; Arrick BA
Cancer Res; 1999 May; 59(10):2292-6. PubMed ID: 10344731
[TBL] [Abstract][Full Text] [Related]
9. Complete primary structure of the human estrogen-responsive gene (pS2) product.
Mori K; Fujii R; Kida N; Takahashi H; Ohkubo S; Fujino M; Ohta M; Hayashi K
J Biochem; 1990 Jan; 107(1):73-6. PubMed ID: 2185238
[TBL] [Abstract][Full Text] [Related]
10. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
11. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer.
Rio MC; Chambon P
Cancer Cells; 1990; 2(8-9):269-74. PubMed ID: 2223388
[TBL] [Abstract][Full Text] [Related]
12. Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors.
Zheng S; Chen P; McMillan A; Lafuente A; Lafuente MJ; Ballesta A; Trias M; Wiencke JK
Carcinogenesis; 2000 Nov; 21(11):2057-64. PubMed ID: 11062168
[TBL] [Abstract][Full Text] [Related]
13. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
[TBL] [Abstract][Full Text] [Related]
14. The 5' flanking region of the human pS2 gene mediates its transcriptional activation by estrogen in MCF-7 cells.
Roberts M; Wallace J; Jeltsch JM; Berry M
Biochem Biophys Res Commun; 1988 Feb; 151(1):306-13. PubMed ID: 2450536
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
Dammann R; Yang G; Pfeifer GP
Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation status of the MUC1 gene coding for a breast-cancer-associated protein.
Zrihan-Licht S; Weiss M; Keydar I; Wreschner DH
Int J Cancer; 1995 Jul; 62(3):245-51. PubMed ID: 7628867
[TBL] [Abstract][Full Text] [Related]
17. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
18. The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein.
Nunez AM; Berry M; Imler JL; Chambon P
EMBO J; 1989 Mar; 8(3):823-9. PubMed ID: 2498085
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-dependent formation of two distinct multiprotein complexes on the human pS2 gene regulatory segment. Participation of a c-fos related protein.
Schuh TJ; Mueller GC
Receptor; 1993; 3(2):125-43. PubMed ID: 8251952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
